Needham Starts Neumora Therapeutics (NMRA) at Buy
Tweet
Share
E-mailGet Alerts NMRA Hot Sheet
Price: $1.52 -5%
Rating Summary:
7 Buy, 2 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 6
Rating Summary:
7 Buy, 2 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 6
Join SI Premium – FREE
Needham analyst Ami Fadia initiates coverage on Neumora Therapeutics (NASDAQ: NMRA) with a Buy rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Neumora Therapeutics click here. For more ratings news on Neumora Therapeutics click here.
Shares of Neumora Therapeutics closed at $11.28 yesterday.
You May Also Be Interested In
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Wedbush Starts Immunic Inc. (IMUX) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
